๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Experimental basis for the clinical use of diphosphonates in paget's disease of bone

โœ Scribed by Herbert Fleisch

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
938 KB
Volume
23
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of etidronate (ehdp) in paget's dise
Use of etidronate (ehdp) in paget's disease of bone
โœ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 382 KB ๐Ÿ‘ 1 views

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients

The Paget Foundation : For Paget's disea
The Paget Foundation : For Paget's disease of bone and related disorders
โœ Charlene Waldman ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 27 KB ๐Ÿ‘ 1 views

In 1978, The Paget Foundation was founded as an organization devoted to providing information concerning Paget's disease of bone to patients and medical professionals. Over the years, the Foundation expanded its programs to include other disorders of abnormal bone resorption, including primary hyper

Arthritis in paget's disease of bone
Arthritis in paget's disease of bone
โœ Roy D. Altman ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 365 KB ๐Ÿ‘ 1 views